Terms: = Leukemia AND KAT6A AND Diagnosis
4 results:
1. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) kat6a/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
Ananthaneni A; Benzar T; Hafiz N; Akabane H
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
[TBL] [Abstract] [Full Text] [Related]
2. A Case of Neonatal Myeloid Sarcoma.
Burdick H; Bormann J; Wagner K; Kerkvliet A
S D Med; 2022 Sep; 75(9):390-391. PubMed ID: 36881822
[TBL] [Abstract] [Full Text] [Related]
3. Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia.
Ling VY; Straube J; Godfrey W; Haldar R; Janardhanan Y; Cooper L; Bruedigam C; Cooper E; Tavakoli Shirazi P; Jacquelin S; Tey SK; Baell J; Huang F; Jin J; Zhao Y; Bullinger L; Bywater MJ; Lane SW
Leukemia; 2023 Jan; 37(1):143-153. PubMed ID: 36400926
[TBL] [Abstract] [Full Text] [Related]
4. Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of kat6a-CREBBP in acute myeloid leukemia.
Panagopoulos I; Torkildsen S; Gorunova L; Tierens A; Tjønnfjord GE; Heim S
PLoS One; 2014; 9(5):e96570. PubMed ID: 24798186
[TBL] [Abstract] [Full Text] [Related]
